NL1033190A1 - Synthese van verbindingen van borium met esters en zuren. - Google Patents

Synthese van verbindingen van borium met esters en zuren.

Info

Publication number
NL1033190A1
NL1033190A1 NL1033190A NL1033190A NL1033190A1 NL 1033190 A1 NL1033190 A1 NL 1033190A1 NL 1033190 A NL1033190 A NL 1033190A NL 1033190 A NL1033190 A NL 1033190A NL 1033190 A1 NL1033190 A1 NL 1033190A1
Authority
NL
Netherlands
Prior art keywords
boron
esters
synthesis
acids
compounds
Prior art date
Application number
NL1033190A
Other languages
English (en)
Other versions
NL1033190C2 (nl
Inventor
I Fraser Pickersgill
John Bischop
Christoph Koellner
Jean-Marc Gomez
Achim Geiser
Robert Hett
Vince Ammoscato
Stephen Munk
Young Lo
Fang-Ting Chiu
Vithalanand R Kulkami
Original Assignee
Millennium Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34968044&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL1033190(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Millennium Pharm Inc filed Critical Millennium Pharm Inc
Publication of NL1033190A1 publication Critical patent/NL1033190A1/nl
Application granted granted Critical
Publication of NL1033190C2 publication Critical patent/NL1033190C2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/04—Esters of boric acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NL1033190A 2004-03-30 2007-01-08 Synthese van verbindingen van borium met esters en zuren. NL1033190C2 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55753504P 2004-03-30 2004-03-30
US55753504 2004-03-30

Publications (2)

Publication Number Publication Date
NL1033190A1 true NL1033190A1 (nl) 2007-04-23
NL1033190C2 NL1033190C2 (nl) 2007-11-27

Family

ID=34968044

Family Applications (3)

Application Number Title Priority Date Filing Date
NL1028639A NL1028639C2 (nl) 2004-03-30 2005-03-29 Synthese van verbindingen van borium met esters en zuren.
NL1033189A NL1033189C2 (nl) 2004-03-30 2007-01-08 Synthese van verbindingen van borium met esters en zuren.
NL1033190A NL1033190C2 (nl) 2004-03-30 2007-01-08 Synthese van verbindingen van borium met esters en zuren.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
NL1028639A NL1028639C2 (nl) 2004-03-30 2005-03-29 Synthese van verbindingen van borium met esters en zuren.
NL1033189A NL1033189C2 (nl) 2004-03-30 2007-01-08 Synthese van verbindingen van borium met esters en zuren.

Country Status (41)

Country Link
US (14) US7714159B2 (nl)
EP (5) EP2377868A1 (nl)
JP (4) JP4558039B2 (nl)
KR (1) KR100939598B1 (nl)
CN (5) CN107474062A (nl)
AR (3) AR049374A1 (nl)
AT (1) ATE521612T1 (nl)
AU (1) AU2005230930B2 (nl)
BR (1) BRPI0509587A (nl)
CA (4) CA2560886C (nl)
CL (2) CL2010000350A1 (nl)
CR (1) CR8653A (nl)
CY (3) CY1112053T1 (nl)
DK (4) DK4008721T3 (nl)
DO (1) DOP2011000293A (nl)
EA (1) EA012927B1 (nl)
EC (1) ECSP066960A (nl)
ES (4) ES2371652T3 (nl)
FI (1) FI4008721T3 (nl)
HK (4) HK1100004A1 (nl)
HR (4) HRP20240307T3 (nl)
HU (1) HUE056859T2 (nl)
IL (3) IL178250A (nl)
LT (2) LT3385267T (nl)
ME (1) ME01975B (nl)
MX (1) MX367324B (nl)
MY (1) MY145427A (nl)
NL (3) NL1028639C2 (nl)
NO (4) NO338905B1 (nl)
NZ (3) NZ586824A (nl)
PE (3) PE20060162A1 (nl)
PL (4) PL1756121T3 (nl)
PT (4) PT1756121E (nl)
RS (4) RS62738B1 (nl)
SG (5) SG182998A1 (nl)
SI (4) SI2377869T1 (nl)
TW (1) TWI386212B (nl)
UA (1) UA90108C2 (nl)
UY (3) UY28830A1 (nl)
WO (1) WO2005097809A2 (nl)
ZA (1) ZA200608689B (nl)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083903A (en) * 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
EP2377868A1 (en) 2004-03-30 2011-10-19 Millennium Pharmaceuticals, Inc. Synthesis of Bortezomib
WO2008075376A1 (en) * 2006-12-18 2008-06-26 Natco Pharma Limited Polymorphic forms of bortezomib and process for their preparation
WO2009004350A1 (en) * 2007-07-03 2009-01-08 Pliva Hrvatska D.O.O. Methods for preparing bortezomib and intermediates used in its manufacture
AU2016253697A1 (en) * 2007-08-06 2016-11-24 Millennium Pharmaceuticals, Inc. Proteasome inhibitors
US7442830B1 (en) 2007-08-06 2008-10-28 Millenium Pharmaceuticals, Inc. Proteasome inhibitors
PL2178888T3 (pl) * 2007-08-06 2012-11-30 Millennium Pharm Inc Inhibitory proteasomów
EA034601B1 (ru) * 2007-08-06 2020-02-25 Милленниум Фармасьютикалз, Инк. Способ получения бороновых кислот
WO2009026579A1 (en) * 2007-08-23 2009-02-26 Cornell Research Foundation, Inc. Proteasome inhibitors and their use in treating pathogen infection and cancer
JP2010539183A (ja) * 2007-09-12 2010-12-16 ドクター・レディーズ・ラボラトリーズ・リミテッド ボルテゾミブおよびその生成のためのプロセス
US7838673B2 (en) 2007-10-16 2010-11-23 Millennium Pharmaceuticals, Inc. Proteasome inhibitors
GEP201706703B (en) 2008-06-17 2017-07-25 Millennium Pharmaceuticals Inc (A Delaware Corporation) Boronate ester compounds and pharmaceutical compositions thereof
AU2013204896A1 (en) * 2008-09-29 2013-05-16 Millennium Pharmaceuticals, Inc. Derivatives of 1-amino-2-cyclobutylethylboronic acid
AR075090A1 (es) 2008-09-29 2011-03-09 Millennium Pharm Inc Derivados de acido 1-amino-2-ciclobutiletilboronico inhibidores de proteosoma,utiles como agentes anticancerigenos, y composiciones farmaceuticas que los comprenden.
EP2238973A1 (en) 2009-04-07 2010-10-13 Cephalon France Lyophilized preparations of proteasome inhibitors
CN101899062B (zh) * 2009-05-26 2015-04-15 上海威智医药科技有限公司 α-手性硼酸及硼酸酯的合成工艺
US9315525B2 (en) 2009-06-19 2016-04-19 Lek Pharmaceuticals D.D. Synthetic route for the preparation of α-amino boronic acid derivatives via substituted alk-1-ynes
EP2270019A1 (en) 2009-06-19 2011-01-05 LEK Pharmaceuticals d.d. New synthetic route for the preparation of alpha-amino boronic esters
EP2280016A1 (en) 2009-07-27 2011-02-02 LEK Pharmaceuticals d.d. New synthetic route for the preparation of alpha-amino boronic esters via substituted alk-1-ynes
CN102725300B (zh) 2009-12-22 2015-03-11 赛福伦公司 蛋白酶体抑制剂及其制备、纯化、和应用的方法
US20110178287A1 (en) 2010-01-19 2011-07-21 Cerulean Pharma Inc. Cyclodextrin-based polymers for therapeutic delivery
US20130085277A1 (en) 2010-02-09 2013-04-04 Ranbaxy Laboratories Limited Process for the preparation of bortezomib
CN101781326B (zh) * 2010-02-11 2013-08-21 福建南方制药股份有限公司 一种制备手性氨基硼酸的中间体及其制备方法
WO2011107912A1 (en) 2010-03-04 2011-09-09 Ranbaxy Laboratories Limited Polymorphic forms of bortezomib
US9061037B2 (en) * 2010-03-18 2015-06-23 Innopharma, Inc. Stable bortezomib formulations
US8263578B2 (en) 2010-03-18 2012-09-11 Innopharma, Inc. Stable bortezomib formulations
US8513218B2 (en) 2010-03-31 2013-08-20 Millennium Pharmaceuticals, Inc. Derivatives of 1-amino-2-cyclopropylethylboronic acid
CN101812026B (zh) * 2010-04-12 2013-08-28 亚邦医药股份有限公司 一种硼替佐米的合成方法
CA2799202C (en) 2010-05-18 2016-07-05 Cerulean Pharma Inc. Compositions and methods for treatment of autoimmune and other diseases
EP2627636B1 (en) 2010-10-14 2015-09-02 Synthon BV Process for making bortezomib and the intermediates for the process
TW201309303A (zh) 2011-03-03 2013-03-01 Cephalon Inc 用於治療狼瘡的蛋白酶體抑制劑
CN102206188B (zh) * 2011-04-08 2013-02-27 苏州二叶制药有限公司 N-(吡嗪-2-基羰基)-l-苯丙氨酸的制备方法
US8497374B2 (en) 2011-05-12 2013-07-30 Scinopharm Taiwan, Ltd. Process for preparing and purifying bortezomib
CN102268029B (zh) * 2011-05-19 2013-10-09 苏州二叶制药有限公司 化合物（1s,2s,3r,5s）-蒎烷二醇-l-苯丙氨酸-l-亮氨酸硼酸酯的制备
WO2012177835A1 (en) 2011-06-22 2012-12-27 Cephalon, Inc. Proteasome inhibitors and processes for their preparation, purification and use
CN102351890B (zh) * 2011-09-30 2014-07-02 重庆泰濠制药有限公司 一种硼替佐米的合成方法
CN102492021B (zh) * 2011-12-13 2013-10-23 重庆泰濠制药有限公司 硼替佐米的制备工艺
SG11201403254QA (en) 2011-12-22 2014-07-30 Ares Trading Sa Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors
CN103374026A (zh) * 2012-04-27 2013-10-30 重庆医药工业研究院有限责任公司 一种硼替佐米中间体的制备方法
CN103450331B (zh) * 2012-06-05 2016-05-25 山东新时代药业有限公司 一种硼替佐米的精制方法
KR20150067175A (ko) * 2012-09-11 2015-06-17 시플라 리미티드 보르테조밉을 제조하기 위한 방법
WO2014072985A1 (en) 2012-11-06 2014-05-15 Natco Pharma Limited Novel boronic acid derivatives as anti cancer agents
CA2891822A1 (en) 2012-11-16 2014-05-22 Shilpa Medicare Limited Crystalline bortezomib process
EP2928898B1 (en) 2012-12-07 2021-04-14 Venatorx Pharmaceuticals, Inc. Beta-lactamase inhibitors
CN103897027A (zh) * 2012-12-29 2014-07-02 曹亚英 关键中间体晶型，制备方法及其在硼替佐米合成中的运用
CN103897026A (zh) * 2012-12-29 2014-07-02 朱继东 硼替佐米关键中间体的晶型，制备方法及其运用
WO2014110442A1 (en) 2013-01-10 2014-07-17 VenatoRx Pharmaceuticals, Inc. Beta-lactamase inhibitors
IN2013MU01431A (nl) 2013-04-16 2015-06-26 Cipla Ltd
CN104211758B (zh) * 2013-05-29 2020-06-12 深圳翰宇药业股份有限公司 一种硼替佐米的制备方法
CN103497233B (zh) * 2013-09-30 2015-04-08 哈药集团技术中心 一种硼替佐米的制备方法
CN103554219A (zh) * 2013-10-01 2014-02-05 昆明贵研药业有限公司 一种制备硼替佐米的方法
KR101691353B1 (ko) * 2013-12-09 2016-12-30 주식회사 경보제약 보르테조밉의 제조방법 및 그의 신규 중간체
US10167311B2 (en) 2014-02-03 2019-01-01 Ohio State Innovation Foundation Boronic acid esters and pharmaceutical formulations thereof
MA39964A (fr) 2014-05-20 2015-11-26 Millennium Pharm Inc Inhibiteurs du protéasome contenant du bore destinés à être utilisés après une thérapie contre le cancer primaire
RU2686740C2 (ru) 2014-06-11 2019-04-30 Венаторкс Фармасьютикалс, Инк. Ингибиторы бета-лактамазы
JP6420629B2 (ja) * 2014-10-30 2018-11-07 ボーグワーナー インコーポレーテッド チェーンガイドおよびチェーンテンショナアーム
DE102015204151A1 (de) * 2015-03-09 2016-09-15 Adidas Ag Ball, insbesondere Fußball, und Verfahren zur Herstellung eines Balls
JP6223508B2 (ja) * 2016-06-27 2017-11-01 ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． プロテアソーム阻害剤
WO2018027062A1 (en) 2016-08-04 2018-02-08 VenatoRx Pharmaceuticals, Inc. Boron-containing compounds
AU2018221670B2 (en) 2017-02-17 2021-02-04 Fresenius Kabi Oncology Ltd. An improved process for the preparation of boronic acid esters
CN110678186A (zh) 2017-03-06 2020-01-10 维纳拓尔斯制药公司 包含β-内酰胺酶抑制剂的固体形式和组合式组合物及其用途
US11332485B2 (en) 2017-05-26 2022-05-17 VenatoRx Pharmaceuticals, Inc. Penicillin-binding protein inhibitors
WO2018218154A1 (en) 2017-05-26 2018-11-29 VenatoRx Pharmaceuticals, Inc. Penicillin-binding protein inhibitors
CN109305980B (zh) 2017-07-28 2022-10-11 成都奥璟生物科技有限公司 一种硼酸酯化合物、其合成方法及其用途
EP3676272A4 (en) * 2017-09-02 2021-04-21 Sun Pharmaceutical Industries Limited IXAZOMIB CITRATE PREPARATION PROCESS
CN111187336B (zh) * 2018-11-14 2022-05-20 正大天晴药业集团股份有限公司 硼替佐米的精制方法
US11964993B2 (en) 2021-07-03 2024-04-23 Shilpa Pharma Lifesciences Limited Crystalline bortezomib process

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4525309A (en) * 1983-03-15 1985-06-25 Washington State University Research Foundation, Inc. Lewis acid catalysis of the homologation of boronic esters with haloalkylmetal reagents
US4537773A (en) 1983-12-05 1985-08-27 E. I. Du Pont De Nemours And Company α-Aminoboronic acid derivatives
US4499082A (en) 1983-12-05 1985-02-12 E. I. Du Pont De Nemours And Company α-Aminoboronic acid peptides
US4701545A (en) 1986-02-12 1987-10-20 Washington State University Research Foundation, Inc. Preparation of α,α-dihaloalkyl boronic esters
US5250720A (en) 1987-06-05 1993-10-05 The Dupont Merck Pharmaceutical Company Intermediates for preparing peptide boronic acid inhibitors of trypsin-like proteases
US5187157A (en) 1987-06-05 1993-02-16 Du Pont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
US5242904A (en) 1987-06-05 1993-09-07 The Dupont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
EP0315574A3 (de) 1987-11-05 1990-08-22 Hoechst Aktiengesellschaft Renin-Inhibitoren
US5106948A (en) 1988-05-27 1992-04-21 Mao Foundation For Medical Education And Research Cytotoxic boronic acid peptide analogs
US6083903A (en) * 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
EP1355910B1 (en) 2001-01-25 2011-03-09 The United States of America, represented by the Secretary, Department of Health and Human Services Formulation of boronic acid compounds
WO2003033507A1 (fr) 2001-10-12 2003-04-24 Kyorin Pharmaceutical Co., Ltd. Derives d'acide benzylmalonique et inhibiteurs de proteasomes les contenant
JPWO2003033506A1 (ja) * 2001-10-12 2005-02-03 杏林製薬株式会社 アミノボラン酸誘導体およびそれを含有するプロテアソーム阻害薬
EP2377868A1 (en) 2004-03-30 2011-10-19 Millennium Pharmaceuticals, Inc. Synthesis of Bortezomib
WO2009004350A1 (en) * 2007-07-03 2009-01-08 Pliva Hrvatska D.O.O. Methods for preparing bortezomib and intermediates used in its manufacture
US7838673B2 (en) * 2007-10-16 2010-11-23 Millennium Pharmaceuticals, Inc. Proteasome inhibitors
US9315525B2 (en) * 2009-06-19 2016-04-19 Lek Pharmaceuticals D.D. Synthetic route for the preparation of α-amino boronic acid derivatives via substituted alk-1-ynes

Also Published As

Publication number Publication date
EP2377869A1 (en) 2011-10-19
NO20191065A1 (no) 2006-12-22
US20200157143A1 (en) 2020-05-21
US20220204558A1 (en) 2022-06-30
MY145427A (en) 2012-02-15
EP2377869B1 (en) 2014-01-29
HRP20240307T3 (hr) 2024-05-10
PT4008721T (pt) 2024-03-21
PT1756121E (pt) 2011-11-30
SI3385267T1 (sl) 2022-04-29
ES2371652T3 (es) 2012-01-05
LT3385267T (lt) 2021-11-10
NZ598172A (en) 2013-08-30
CN107474062A (zh) 2017-12-15
NL1028639C2 (nl) 2007-01-17
RS51983B (en) 2012-02-29
US20130005968A1 (en) 2013-01-03
US20210395301A1 (en) 2021-12-23
IL178250A0 (en) 2006-12-31
US20050240047A1 (en) 2005-10-27
WO2005097809A3 (en) 2006-02-16
NZ550522A (en) 2010-08-27
ATE521612T1 (de) 2011-09-15
CA2738706C (en) 2014-10-14
CN108329337B (zh) 2021-06-25
NO338905B1 (no) 2016-10-31
JP4558039B2 (ja) 2010-10-06
KR100939598B1 (ko) 2010-02-01
HK1100004A1 (en) 2007-08-31
ES2974758T3 (es) 2024-07-01
US20190112334A1 (en) 2019-04-18
HK1257298A1 (zh) 2019-10-18
EP4008721A1 (en) 2022-06-08
US10000529B2 (en) 2018-06-19
ZA200608689B (en) 2007-09-26
AU2005230930A1 (en) 2005-10-20
JP5894952B2 (ja) 2016-03-30
AR049374A1 (es) 2006-07-26
IL219856A0 (en) 2012-06-28
JP2010241816A (ja) 2010-10-28
CN1960996B (zh) 2016-04-20
HRP20140339T1 (hr) 2014-05-09
US20210171574A1 (en) 2021-06-10
PL4008721T3 (pl) 2024-05-13
ES2457593T3 (es) 2014-04-28
PL2377869T3 (pl) 2014-07-31
EP4008721B1 (en) 2024-01-03
BRPI0509587A (pt) 2007-09-25
DOP2011000293A (es) 2011-12-15
EP1756121B1 (en) 2011-08-24
IL219856A (en) 2015-05-31
NZ586824A (en) 2012-03-30
JP2016056180A (ja) 2016-04-21
NO20064893L (no) 2006-12-22
TW200616646A (en) 2006-06-01
EP3385267B1 (en) 2021-09-29
US7714159B2 (en) 2010-05-11
PT3385267T (pt) 2021-11-23
HRP20110846T1 (hr) 2011-12-31
FI4008721T3 (fi) 2024-03-19
DK4008721T3 (da) 2024-03-25
RS65253B1 (sr) 2024-03-29
ME01975B (me) 2015-05-20
AU2005230930B2 (en) 2011-09-29
NO20171939A1 (no) 2006-12-22
IL219853A0 (en) 2012-06-28
NO20161350A1 (no) 2006-12-22
RS62738B1 (sr) 2022-01-31
PT2377869E (pt) 2014-04-15
CL2014002252A1 (es) 2014-12-05
UY35578A (es) 2016-01-08
US20150038706A1 (en) 2015-02-05
US20200369722A1 (en) 2020-11-26
ES2899606T3 (es) 2022-03-14
CA2560886A1 (en) 2005-10-20
CY1115336T1 (el) 2017-01-04
US8283467B2 (en) 2012-10-09
US20160362449A1 (en) 2016-12-15
EP3385267A1 (en) 2018-10-10
AR097309A2 (es) 2016-03-02
EA200601795A1 (ru) 2007-04-27
EP2377868A1 (en) 2011-10-19
EP1756121A2 (en) 2007-02-28
US9862745B2 (en) 2018-01-09
NL1033189A1 (nl) 2007-10-22
SG10201600029PA (en) 2016-02-26
KR20070007873A (ko) 2007-01-16
CY1112053T1 (el) 2015-11-04
PE20110075A1 (es) 2011-02-17
SI1756121T1 (sl) 2012-03-30
UY34969A (es) 2015-02-27
JP6193960B2 (ja) 2017-09-06
SI4008721T1 (sl) 2024-05-31
EA012927B1 (ru) 2010-02-26
SG10201800972PA (en) 2018-03-28
ECSP066960A (es) 2006-12-20
US20180265546A1 (en) 2018-09-20
PE20142402A1 (es) 2015-02-04
WO2005097809A2 (en) 2005-10-20
MX367324B (es) 2019-08-15
RS53259B (en) 2014-08-29
TWI386212B (zh) 2013-02-21
CA2738706A1 (en) 2005-10-20
DK1756121T3 (da) 2012-01-09
CN111925385B (zh) 2023-11-21
JP5414625B2 (ja) 2014-02-12
CN111925385A (zh) 2020-11-13
UA90108C2 (uk) 2010-04-12
CA2859119A1 (en) 2005-10-20
HK1246300A1 (zh) 2018-09-07
IL178250A (en) 2012-06-28
IL219853A (en) 2015-05-31
HUE056859T2 (hu) 2022-03-28
CN103396427B (zh) 2018-04-13
DK2377869T3 (da) 2014-04-14
NL1028639A1 (nl) 2005-10-20
CR8653A (es) 2007-10-23
CY1124753T1 (el) 2022-07-22
SG182998A1 (en) 2012-08-30
DK3385267T3 (da) 2021-11-01
CL2010000350A1 (es) 2011-01-28
HK1164320A1 (en) 2012-10-19
US20190330270A1 (en) 2019-10-31
PE20060162A1 (es) 2006-04-07
NO344610B1 (no) 2020-02-10
SG182999A1 (en) 2012-08-30
CA2853272A1 (en) 2005-10-20
CN103396427A (zh) 2013-11-20
CA2560886C (en) 2014-08-12
CN1960996A (zh) 2007-05-09
AR097310A2 (es) 2016-03-02
JP2007530687A (ja) 2007-11-01
NL1033190C2 (nl) 2007-11-27
NO343966B1 (no) 2019-07-29
CN108329337A (zh) 2018-07-27
LT4008721T (lt) 2024-03-25
SI2377869T1 (sl) 2014-05-30
HRP20212002T1 (hr) 2022-04-01
UY28830A1 (es) 2005-09-30
SG151322A1 (en) 2009-04-30
PL1756121T3 (pl) 2012-02-29
NL1033189C2 (nl) 2008-08-14
US20100174072A1 (en) 2010-07-08
US20180044377A1 (en) 2018-02-15
PL3385267T3 (pl) 2022-02-14
JP2013100378A (ja) 2013-05-23

Similar Documents

Publication Publication Date Title
NL1033189A1 (nl) Synthese van verbindingen van borium met esters en zuren.
IL186297A0 (en) N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use
IL216705A0 (en) Methods of synthesis of phthalazinone derivative and intermediates in the synthesis
EP1857433A4 (en) ESTERIFICATION REACTION PRODUCT AND BEAUTY PRODUCT
EP1954788A4 (en) COMBUSTION CATALYST SUPPORT AND METHOD OF USE THEREOF
DE502006000549D1 (de) Rollo eben zur Umgebungsfläche
ZA200609727B (en) Carbonylation of ester
DE502006003169D1 (de) Verfahren zur enzymatischen Synthese von Triglyceriden
HK1118804A1 (en) Novel unsaturated fatty hydroxy acid derivatives and the dermocosmetologic use thereof
ATE417818T1 (de) Katalytisches eintopfverfahren zur synthese von isocyanaten
AU305622S (en) USB driver having MP3 function
DE112008002579A5 (de) Verfahren zur Synthese von A-Ring-Aromatisierten Acetyl-Minocyclinen
BRPI0716766A2 (pt) Ésteres de nitrato de aminoÁlcoois
EP1771579A4 (en) DESIGN, SYNTHESIS AND ARRANGEMENT OF SYNTHETIC NUCLEIC ACIDS
GB0410603D0 (en) Ester synthesis
DE602006014845D1 (de) Zweistufiges verfahren zur herstellung von fettsäuren
ATE479663T1 (de) Stereoselektive synthese von (s)-1-methyl-3- phenylpiperazin
ITMI20061987A1 (it) Processo per la sintesi di arilossipropilammine ed eteroarilossipropilammine.
ATE402145T1 (de) Synthese von pyrrol-2-carbonsäurenitrilen
GB0523402D0 (en) Carbonylation of vinyl ester
ATE374742T1 (de) Synthese von 2-chlormethyl-6- methylbenzoesäureestern
GB0421012D0 (en) Ester synthesis
UA13593S (uk) Спинка ліжка
ES1062722Y (es) Panel fono-absorbente perfeccionado con fines decorativos
PL380621A1 (pl) Nowe heterogenizowane kompleksy rodu oraz sposób ich otrzymywania

Legal Events

Date Code Title Description
AD1A A request for search or an international type search has been filed
RD2N Patents in respect of which a decision has been taken or a report has been made (novelty report)

Effective date: 20070726

PD2B A search report has been drawn up
MM Lapsed because of non-payment of the annual fee

Effective date: 20220401